LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Lifecore Biomedical, Inc. \De\ quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q3 2011 to Q2 2024.
  • Lifecore Biomedical, Inc. \De\ Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending May 26, 2024 was -$7.08M, a 82% increase year-over-year.
  • Lifecore Biomedical, Inc. \De\ Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending May 26, 2024 was $12M.
  • Lifecore Biomedical, Inc. \De\ annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $12M.
  • Lifecore Biomedical, Inc. \De\ annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$99M, a 14.6% increase from 2021.
  • Lifecore Biomedical, Inc. \De\ annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$116M, a 276% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $12M -$7.08M +$32.2M +82% Feb 26, 2024 May 26, 2024 10-K 2024-08-26
Q1 2024 -$20.2M $15.6M +$52.1M Nov 27, 2023 Feb 25, 2024 10-Q 2024-08-09
Q4 2023 -$72.3M $14.2M +$26.7M Aug 28, 2023 Nov 26, 2023 10-Q 2024-08-09
Q3 2023 -$99.1M -$10.8M -$88K -0.83% May 29, 2023 Aug 27, 2023 10-Q 2024-08-09
Q2 2023 -$99M -$39.3M +$15.9M +28.8% Feb 27, 2023 May 28, 2023 10-K 2024-08-26
Q1 2023 -$115M -$36.5M -$23M -171% Nov 28, 2022 Feb 26, 2023 10-Q 2024-08-09
Q4 2022 -$91.8M -$12.5M +$25.8M +67.3% Aug 29, 2022 Nov 27, 2022 10-Q 2024-08-09
Q3 2022 -$118M -$10.7M -$1.65M -18.2% May 30, 2022 Aug 28, 2022 10-Q 2024-08-09
Q2 2022 -$116M -$55.1M -$54.2M -5862% Feb 28, 2022 May 29, 2022 10-K 2024-08-26
Q1 2022 -$61.7M -$13.5M -$6.89M -105% Nov 29, 2021 Feb 27, 2022 10-K 2024-03-20
Q4 2021 -$54.8M -$38.3M -$27.1M -241% Aug 30, 2021 Nov 28, 2021 10-K 2024-03-20
Q3 2021 -$27.8M -$9.02M +$3.09M +25.5% May 31, 2021 Aug 29, 2021 10-K 2024-03-20
Q2 2021 -$30.8M -$925K +$16.2M +94.6% Mar 1, 2021 May 30, 2021 10-K 2024-03-20
Q1 2021 -$47M -$6.59M +$5.34M +44.7% Nov 30, 2020 Feb 28, 2021 10-K 2024-03-20
Q4 2020 -$52.4M -$11.2M -$4.61M -69.7% Aug 31, 2020 Nov 29, 2020 10-K 2024-03-20
Q3 2020 -$47.8M -$12.1M -$6.71M -124% Jun 1, 2020 Aug 30, 2020 10-K 2024-03-20
Q2 2020 -$41.1M -$17.1M Feb 24, 2020 May 31, 2020 10-K/A 2023-03-16
Q1 2020 -$11.9M -$12.4M -2627% Nov 25, 2019 Feb 23, 2020 10-Q 2021-04-08
Q4 2019 -$6.61M -$6.11M -1202% Aug 26, 2019 Nov 24, 2019 10-Q 2021-01-07
Q3 2019 -$5.4M May 27, 2019 Aug 25, 2019 10-Q 2020-10-07
Q1 2019 $472K Nov 26, 2018 Feb 24, 2019 10-Q 2020-04-03
Q4 2018 -$508K Aug 27, 2018 Nov 25, 2018 10-Q 2020-01-02
Q1 2017 $13.3M $3.6M +$24.8M Nov 28, 2016 Feb 26, 2017 10-Q 2017-04-07
Q4 2016 -$11.5M $1.65M -$215K -11.5% Aug 29, 2016 Nov 27, 2016 10-Q 2017-01-05
Q3 2016 -$11.3M $3.31M +$360K +12.2% May 30, 2016 Aug 28, 2016 10-Q 2016-09-29
Q2 2016 -$11.6M $4.73M +$533K +12.7% Mar 1, 2016 May 29, 2016 10-K 2016-08-01
Q1 2016 -$12.2M -$21.2M -$25M -662% Nov 30, 2015 Feb 28, 2016 10-Q 2017-04-07
Q4 2015 $12.8M $1.87M -$1.36M -42% Aug 31, 2015 Nov 29, 2015 10-Q 2017-01-05
Q3 2015 $14.1M $2.95M +$599K +25.5% Jun 1, 2015 Aug 30, 2015 10-Q 2016-09-29
Q2 2015 $13.5M $4.2M -$346K -7.62% Mar 2, 2015 May 31, 2015 10-K 2016-08-01
Q1 2015 $13.9M $3.77M -$2.63M -41.1% Dec 1, 2014 Mar 1, 2015 10-K 2016-08-01
Q4 2014 $16.5M $3.22M -$228K -6.61% Sep 1, 2014 Nov 30, 2014 10-K 2016-08-01
Q3 2014 $16.7M $2.35M -$2.4M -50.5% Jun 2, 2014 Aug 31, 2014 10-Q 2015-10-01
Q2 2014 $19.1M $4.54M +$23K +0.51% Feb 24, 2014 May 25, 2014 10-K 2016-08-01
Q1 2014 $19.1M $6.4M +$1.61M +33.6% Nov 25, 2013 Feb 23, 2014 10-K 2016-08-01
Q4 2013 $17.5M $3.45M -$5.46M -61.3% Aug 26, 2013 Nov 24, 2013 10-K 2016-08-01
Q3 2013 $23M $4.75M +$386K +8.84% May 27, 2013 Aug 25, 2013 10-K 2016-08-01
Q2 2013 $22.6M $4.52M +$1.74M +62.6% Feb 25, 2013 May 26, 2013 10-K 2015-07-31
Q1 2013 $20.8M $4.79M +$24K +0.5% Nov 26, 2012 Feb 24, 2013 10-K 2015-07-31
Q4 2012 $20.8M $8.91M +$5.57M +167% Aug 27, 2012 Nov 25, 2012 10-K 2015-07-31
Q3 2012 $15.3M $4.37M +$2.55M +141% May 28, 2012 Aug 26, 2012 10-K 2015-07-31
Q2 2012 $12.7M $2.78M Feb 27, 2012 May 27, 2012 10-K 2014-08-01
Q1 2012 $4.77M Nov 28, 2011 Feb 26, 2012 10-K 2014-08-01
Q4 2011 $3.34M Aug 29, 2011 Nov 27, 2011 10-K 2014-08-01
Q3 2011 $1.81M May 30, 2011 Aug 28, 2011 10-K 2014-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.